109 related articles for article (PubMed ID: 23266729)
1. Sulfated derivatives of 20(S)-ginsenoside Rh2 and their inhibitory effects on LPS-induced inflammatory cytokines and mediators.
Fu BD; Bi WY; He CL; Zhu W; Shen HQ; Yi PF; Wang L; Wang DC; Wei XB
Fitoterapia; 2013 Jan; 84():303-7. PubMed ID: 23266729
[TBL] [Abstract][Full Text] [Related]
2. Inhibitory effects of sulfated 20(S)-ginsenoside Rh2 on the release of pro-inflammatory mediators in LPS-induced RAW 264.7 cells.
Yi PF; Bi WY; Shen HQ; Wei Q; Zhang LY; Dong HB; Bai HL; Zhang C; Song Z; Qin QQ; Lv S; Wu SC; Fu BD; Wei XB
Eur J Pharmacol; 2013 Jul; 712(1-3):60-6. PubMed ID: 23665488
[TBL] [Abstract][Full Text] [Related]
3. Anti-inflammatory, antioxidative and matrix metalloproteinase inhibitory properties of 20(R)-ginsenoside Rh2 in cultured macrophages and keratinocytes.
Choi WY; Lim HW; Lim CJ
J Pharm Pharmacol; 2013 Feb; 65(2):310-6. PubMed ID: 23278699
[TBL] [Abstract][Full Text] [Related]
4. Ginsenosides Rg3 and Rh2 inhibit the activation of AP-1 and protein kinase A pathway in lipopolysaccharide/interferon-gamma-stimulated BV-2 microglial cells.
Bae EA; Kim EJ; Park JS; Kim HS; Ryu JH; Kim DH
Planta Med; 2006 Jun; 72(7):627-33. PubMed ID: 16673329
[TBL] [Abstract][Full Text] [Related]
5. 20(R)-ginsenoside Rh2, not 20(S), is a selective osteoclastgenesis inhibitor without any cytotoxicity.
Liu J; Shiono J; Shimizu K; Yu H; Zhang C; Jin F; Kondo R
Bioorg Med Chem Lett; 2009 Jun; 19(12):3320-3. PubMed ID: 19428246
[TBL] [Abstract][Full Text] [Related]
6. In situ preparation of water-soluble ginsenoside Rh2-entrapped bovine serum albumin nanoparticles: in vitro cytocompatibility studies.
Singh P; Kim YJ; Singh H; Ahn S; Castro-Aceituno V; Yang DC
Int J Nanomedicine; 2017; 12():4073-4084. PubMed ID: 28603419
[TBL] [Abstract][Full Text] [Related]
7. Ginsenoside Rh2-B1 stimulates cell proliferation and IFN-γ production by activating the p38 MAPK and ERK-dependent signaling pathways in CTLL-2 cells.
Lv S; Yi PF; Shen HQ; Zhang LY; Dong HB; Wu SC; Xia F; Guo X; Wei XB; Fu BD
Immunopharmacol Immunotoxicol; 2014 Feb; 36(1):43-51. PubMed ID: 24294901
[TBL] [Abstract][Full Text] [Related]
8. Ginsenoside Rh2 inhibits osteoclastogenesis through down-regulation of NF-κB, NFATc1 and c-Fos.
He L; Lee J; Jang JH; Lee SH; Nan MH; Oh BC; Lee SG; Kim HH; Soung NK; Ahn JS; Kim BY
Bone; 2012 Jun; 50(6):1207-13. PubMed ID: 22484180
[TBL] [Abstract][Full Text] [Related]
9. Ginsenoside Rp1, a ginsenoside derivative, blocks lipopolysaccharide-induced interleukin-1beta production via suppression of the NF-kappaB pathway.
Kim BH; Lee YG; Park TY; Kim HB; Rhee MH; Cho JY
Planta Med; 2009 Mar; 75(4):321-6. PubMed ID: 19145554
[TBL] [Abstract][Full Text] [Related]
10. Stereospecificity of hydroxyl group at C-20 in antiproliferative action of ginsenoside Rh2 on prostate cancer cells.
Liu J; Shimizu K; Yu H; Zhang C; Jin F; Kondo R
Fitoterapia; 2010 Oct; 81(7):902-5. PubMed ID: 20554003
[TBL] [Abstract][Full Text] [Related]
11. [Effects of 20 (S) -ginsenoside Rh2 and 20 (R) -ginsenoside Rh2 on proliferation and apoptosis of human lung adenocarcinoma A549 cells].
Zhang C; Yu H; Hou J
Zhongguo Zhong Yao Za Zhi; 2011 Jun; 36(12):1670-4. PubMed ID: 22007558
[TBL] [Abstract][Full Text] [Related]
12. Increase of adipogenesis by ginsenoside (Rh2) in 3T3-L1 cell via an activation of glucocorticoid receptor.
Niu CS; Yeh CH; Yeh MF; Cheng JT
Horm Metab Res; 2009 Apr; 41(4):271-6. PubMed ID: 19048455
[TBL] [Abstract][Full Text] [Related]
13. Production of the Rare Ginsenoside Rh2-MIX (20(
Song BK; Kim KM; Choi KD; Im WT
J Microbiol Biotechnol; 2017 Jul; 27(7):1233-1241. PubMed ID: 28478658
[TBL] [Abstract][Full Text] [Related]
14. Preparation of Polyethylene Glycol-Ginsenoside Rh1 and Rh2 Conjugates and Their Efficacy against Lung Cancer and Inflammation.
Mathiyalagan R; Wang C; Kim YJ; Castro-Aceituno V; Ahn S; Subramaniyam S; Simu SY; Jiménez-Pérez ZE; Yang DC; Jung SK
Molecules; 2019 Nov; 24(23):. PubMed ID: 31795352
[TBL] [Abstract][Full Text] [Related]
15. Ginsenoside Re ameliorates inflammation by inhibiting the binding of lipopolysaccharide to TLR4 on macrophages.
Lee IA; Hyam SR; Jang SE; Han MJ; Kim DH
J Agric Food Chem; 2012 Sep; 60(38):9595-602. PubMed ID: 22849695
[TBL] [Abstract][Full Text] [Related]
16. Mechanistic studies on protopanaxadiol, Rh2, and ginseng (Panax quinquefolius) extract induced cytotoxicity in intestinal Caco-2 cells.
Popovich DG; Kitts DD
J Biochem Mol Toxicol; 2004; 18(3):143-9. PubMed ID: 15252870
[TBL] [Abstract][Full Text] [Related]
17. Anti-obesity effects of ginsenoside Rh2 are associated with the activation of AMPK signaling pathway in 3T3-L1 adipocyte.
Hwang JT; Kim SH; Lee MS; Kim SH; Yang HJ; Kim MJ; Kim HS; Ha J; Kim MS; Kwon DY
Biochem Biophys Res Commun; 2007 Dec; 364(4):1002-8. PubMed ID: 17971295
[TBL] [Abstract][Full Text] [Related]
18. Ginsenosides 20(S)-protopanaxadiol and Rh2 reduce cell proliferation and increase sub-G1 cells in two cultured intestinal cell lines, Int-407 and Caco-2.
Popovich DG; Kitts DD
Can J Physiol Pharmacol; 2004 Mar; 82(3):183-90. PubMed ID: 15052284
[TBL] [Abstract][Full Text] [Related]
19. Antiallergic activity of ginsenoside Rh2.
Park EK; Choo MK; Kim EJ; Han MJ; Kim DH
Biol Pharm Bull; 2003 Nov; 26(11):1581-4. PubMed ID: 14600405
[TBL] [Abstract][Full Text] [Related]
20. Characterizing the mechanism for ginsenoside-induced cytotoxicity in cultured leukemia (THP-1) cells.
Kitts DD; Popovich DG; Hu C
Can J Physiol Pharmacol; 2007 Nov; 85(11):1173-83. PubMed ID: 18066119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
